Harrow Historical Income Statement

HROWL Stock

USD 25.43 0.08 0.32%

Historical analysis of Harrow Health income statement accounts such as Selling And Marketing Expenses of 5.2 M or Other Operating Expenses of 136.1 M can show how well Harrow Health 8625 performed in making a profits. Evaluating Harrow Health income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Harrow Health's future profits or losses.

Cash Flow Balance Sheet Income Statement

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Harrow Health 8625 latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Harrow Health 8625 is a good buy for the upcoming year.

Net Income Gross Profit

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Harrow Health 8625. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in housing.

For more information on how to buy Harrow Stock please use our How to buy in Harrow Stock guide.

About Harrow Income Statement Analysis

Harrow Health 8625 Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Harrow Health shareholders. The income statement also shows Harrow investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Harrow Health Income Statement Chart

At this time, Harrow Health's EBITDA is quite stable compared to the past year. Total Operating Expenses is expected to rise to about 94.5 M this year, although the value of EBIT will most likely fall to (2.7 M).

Selling General Administrative Selling And Marketing Expenses Other Operating Expenses Research Development

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Harrow Health 8625. It is also known as Harrow Health overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.

Most accounts from Harrow Health's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Harrow Health 8625 current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Harrow Health 8625. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in housing.

For more information on how to buy Harrow Stock please use our How to buy in Harrow Stock guide.At this time, Harrow Health's EBITDA is quite stable compared to the past year. Total Operating Expenses is expected to rise to about 94.5 M this year, although the value of EBIT will most likely fall to (2.7 M).

	2021	2022	2023	2024 (projected)
Total Revenue	72.5M	88.6M	130.2M	136.7M
Depreciation And Amortization	2.4M	3.7M	12.3M	13.0M

Total Revenue Depreciation And Amortization

Harrow Health income statement Correlations

	Interest Expense	Selling General Administrative	Selling And Marketing Expenses	Other Operating Expenses	Operating Income	Ebit	Research Development	Ebitda	Total Operating Expenses	Income Before Tax	Total Other Income Expense Net	Net Income	Income Tax Expense	Depreciation And Amortization	Total Revenue	Gross Profit	Cost Of Revenue	Tax Provision	Interest Income	Net Income From Continuing Ops	Non Recurring	Non Operating Income Net Other	Minority Interest
Interest Expense		0.88	0.44	0.93	0.37	0.15	0.66	0.62	0.93	-0.63	-0.73	-0.65	0.09	0.98	0.91	0.9	0.93	0.18	0.15	-0.67	-0.82	-0.63	0.89
Selling General Administrative	0.88		0.63	0.98	0.52	0.2	0.74	0.61	0.98	-0.47	-0.7	-0.49	0.0	0.89	0.99	0.99	0.98	0.32	0.23	-0.8	-0.88	-0.76	0.69
Selling And Marketing Expenses	0.44	0.63		0.64	-0.08	-0.26	0.39	0.04	0.63	-0.29	-0.2	-0.31	-0.17	0.42	0.59	0.57	0.63	-0.01	0.28	-0.38	-0.39	-0.37	0.27
Other Operating Expenses	0.93	0.98	0.64		0.44	0.14	0.74	0.59	1.0	-0.54	-0.71	-0.56	0.01	0.94	0.99	0.99	0.99	0.24	0.23	-0.77	-0.87	-0.74	0.76
Operating Income	0.37	0.52	-0.08	0.44		0.78	0.55	0.81	0.44	0.13	-0.46	0.1	0.05	0.46	0.54	0.58	0.46	0.48	0.09	-0.51	-0.53	-0.5	0.38
Ebit	0.15	0.2	-0.26	0.14	0.78		0.04	0.86	0.12	0.41	-0.08	0.38	-0.03	0.28	0.22	0.24	0.19	0.55	0.11	0.04	-0.06	0.07	0.27
Research Development	0.66	0.74	0.39	0.74	0.55	0.04		0.37	0.76	-0.53	-0.78	-0.55	0.16	0.65	0.77	0.79	0.69	0.33	0.01	-0.91	-0.85	-0.92	0.53
Ebitda	0.62	0.61	0.04	0.59	0.81	0.86	0.37		0.58	0.01	-0.43	-0.02	0.02	0.73	0.65	0.66	0.63	0.51	0.17	-0.3	-0.46	-0.26	0.67
Total Operating Expenses	0.93	0.98	0.63	1.0	0.44	0.12	0.76	0.58		-0.57	-0.73	-0.59	0.04	0.93	0.99	0.99	0.99	0.26	0.2	-0.79	-0.89	-0.76	0.76
Income Before Tax	-0.63	-0.47	-0.29	-0.54	0.13	0.41	-0.53	0.01	-0.57		0.82	1.0	-0.62	-0.54	-0.49	-0.5	-0.47	0.08	0.51	0.58	0.63	0.57	-0.53
Total Other Income Expense Net	-0.73	-0.7	-0.2	-0.71	-0.46	-0.08	-0.78	-0.43	-0.73	0.82		0.83	-0.61	-0.7	-0.72	-0.75	-0.65	-0.24	0.45	0.82	0.86	0.8	-0.64
Net Income	-0.65	-0.49	-0.31	-0.56	0.1	0.38	-0.55	-0.02	-0.59	1.0	0.83		-0.63	-0.56	-0.52	-0.52	-0.49	0.04	0.51	0.59	0.64	0.58	-0.54
Income Tax Expense	0.09	0.0	-0.17	0.01	0.05	-0.03	0.16	0.02	0.04	-0.62	-0.61	-0.63		0.08	0.02	0.05	-0.04	-0.06	-0.94	-0.15	-0.15	-0.14	0.11
Depreciation And Amortization	0.98	0.89	0.42	0.94	0.46	0.28	0.65	0.73	0.93	-0.54	-0.7	-0.56	0.08		0.93	0.92	0.94	0.22	0.17	-0.63	-0.79	-0.58	0.91
Total Revenue	0.91	0.99	0.59	0.99	0.54	0.22	0.77	0.65	0.99	-0.49	-0.72	-0.52	0.02	0.93		1.0	0.99	0.29	0.22	-0.8	-0.89	-0.76	0.75
Gross Profit	0.9	0.99	0.57	0.99	0.58	0.24	0.79	0.66	0.99	-0.5	-0.75	-0.52	0.05	0.92	1.0		0.98	0.32	0.19	-0.82	-0.91	-0.79	0.75
Cost Of Revenue	0.93	0.98	0.63	0.99	0.46	0.19	0.69	0.63	0.99	-0.47	-0.65	-0.49	-0.04	0.94	0.99	0.98		0.2	0.29	-0.72	-0.83	-0.68	0.77
Tax Provision	0.18	0.32	-0.01	0.24	0.48	0.55	0.33	0.51	0.26	0.08	-0.24	0.04	-0.06	0.22	0.29	0.32	0.2		0.09	-0.3	-0.31	-0.3	0.19
Interest Income	0.15	0.23	0.28	0.23	0.09	0.11	0.01	0.17	0.2	0.51	0.45	0.51	-0.94	0.17	0.22	0.19	0.29	0.09		0.01	-0.01	0.02	0.06
Net Income From Continuing Ops	-0.67	-0.8	-0.38	-0.77	-0.51	0.04	-0.91	-0.3	-0.79	0.58	0.82	0.59	-0.15	-0.63	-0.8	-0.82	-0.72	-0.3	0.01		0.96	1.0	-0.49
Non Recurring	-0.82	-0.88	-0.39	-0.87	-0.53	-0.06	-0.85	-0.46	-0.89	0.63	0.86	0.64	-0.15	-0.79	-0.89	-0.91	-0.83	-0.31	-0.01	0.96		0.94	-0.69
Non Operating Income Net Other	-0.63	-0.76	-0.37	-0.74	-0.5	0.07	-0.92	-0.26	-0.76	0.57	0.8	0.58	-0.14	-0.58	-0.76	-0.79	-0.68	-0.3	0.02	1.0	0.94		-0.45
Minority Interest	0.89	0.69	0.27	0.76	0.38	0.27	0.53	0.67	0.76	-0.53	-0.64	-0.54	0.11	0.91	0.75	0.75	0.77	0.19	0.06	-0.49	-0.69	-0.45

Click cells to compare fundamentals

Harrow Health Account Relationship Matchups

Harrow Health income statement Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Interest Expense	2.5M	2.2M	5.4M	7.2M	21.3M	22.4M
Selling General Administrative	33.1M	31.2M	41.3M	58.2M	67.0M	70.3M
Other Operating Expenses	51.9M	48.1M	70.6M	86.7M	129.6M	136.1M
Operating Income	(503K)	(1.6M)	(284K)	(1.7M)	580K	609K
Ebit	(503K)	748K	(12.5M)	(6.9M)	(2.6M)	(2.7M)
Research Development	2.1M	2.4M	11.1M	3.1M	6.9M	7.2M
Ebitda	2.2M	3.5M	(10.1M)	(3.2M)	9.7M	10.2M
Total Operating Expenses	35.2M	33.7M	52.4M	61.3M	90.0M	94.5M
Income Before Tax	(125K)	(3.4M)	(17.9M)	(14.0M)	(23.9M)	(22.7M)
Total Other Income Expense Net	378K	(3.8M)	(19.5M)	(15.9M)	(24.5M)	(23.3M)
Net Income	(2.6M)	(3.4M)	(18.0M)	(14.1M)	(24.4M)	(23.2M)
Income Tax Expense	2.5M	4K	133K	75K	470K	493.5K
Depreciation And Amortization	2.7M	2.7M	2.4M	3.7M	12.3M	13.0M
Total Revenue	51.2M	48.9M	72.5M	88.6M	130.2M	136.7M
Gross Profit	34.4M	34.4M	54.3M	63.2M	90.6M	95.1M
Cost Of Revenue	16.7M	14.5M	18.2M	25.4M	39.6M	41.6M
Interest Income	5.2M	20.1M	4.0M	3.7M	4.3M	7.9M
Net Income Applicable To Common Shares	168K	(3.4M)	(18.5M)	(14.1M)	(12.7M)	(12.0M)

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

When determining whether Harrow Health 8625 is a strong investment it is important to analyze Harrow Health's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Harrow Health's future performance. For an informed investment choice regarding Harrow Stock, refer to the following important reports:

How To Invest In Harrow

Details

Is Harrow Stock a good investment?

Details

What is Harrow Health's Net Worth?

Details

Largest Pharmaceuticals Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

For more information on how to buy Harrow Stock please use our How to buy in Harrow Stock guide.

You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.

Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Harrow Health. If investors know Harrow will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Harrow Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Return On Equity

0.4484

The market value of Harrow Health 8625 is measured differently than its book value, which is the value of Harrow that is recorded on the company's balance sheet. Investors also form their own opinion of Harrow Health's value that differs from its market value or its book value, called intrinsic value, which is Harrow Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Harrow Health's market value can be influenced by many factors that don't directly affect Harrow Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Harrow Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Harrow Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Harrow Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Harrow Historical Income Statement

About Harrow Income Statement Analysis

Harrow Health Income Statement Chart

Other Operating Expenses

Harrow Health income statement Correlations

Harrow Health Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Harrow Health income statement Accounts

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Operating Expenses	+ 1.0	Other Operating Expenses
Net Income	+ 1.0	Income Before Tax
Gross Profit	+ 1.0	Total Revenue
Non Operating Income Net Other	+ 1.0	Net Income From Continuing Ops
Total Revenue	+ 0.99	Selling General Administrative
Gross Profit	+ 0.99	Selling General Administrative

Interest Income	- 0.94	Income Tax Expense
Non Operating Income Net Other	- 0.92	Research Development
Non Recurring	- 0.91	Gross Profit
Net Income From Continuing Ops	- 0.91	Research Development
Non Recurring	- 0.89	Total Revenue
Non Recurring	- 0.89	Total Operating Expenses